• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有独特临床病理特征的小儿脑肿瘤中 EP300-BCOR 融合的反复出现。

Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.

机构信息

Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.

Department of Pathology.

出版信息

J Neuropathol Exp Neurol. 2019 Apr 1;78(4):305-314. doi: 10.1093/jnen/nlz011.

DOI:10.1093/jnen/nlz011
PMID:30816933
Abstract

BCOR is an epigenetic regulator and is genetically altered by mutation, deletion, or gene fusion in a range of cancers. "Central nervous system high-grade neuroepithelial tumor with BCOR alteration" is a recently described entity with characteristic internal tandem duplications within exon 15 of the BCOR gene (hereafter: CNS HGNET-BCOR ex15 ITD). In this case series of 3 patients, we report the clinicopathologic, molecular, and methylome features of gliomas with novel EP300-BCOR in-frame gene fusions, thus expanding the spectrum of BCOR alterations seen in CNS tumors. The gliomas in this series arise in children (ages 10-18), involve the supratentorial compartment, and have an infiltrative pattern of growth and a myxoid/microcystic background with frequent psammomatous calcifications and prominent chicken-wire vessels. All 3 cases had areas with low-grade morphology and 2 of them demonstrated histologic high-grade transformation. In contrast to CNS HGNET-BCOR ex15 ITD, they lack perivascular pseudorosettes. On a t-Distributed Stochastic Neighbor Embedding plot they cluster perfectly together, away from CNS HGNET-BCOR ex15ITD, consistent with a different entity. Gliomas with EP300-BCOR fusions and high-grade histology can demonstrate relatively rapid regrowth after debulking or subtotal resection.

摘要

BCOR 是一种表观遗传调节剂,在多种癌症中会因突变、缺失或基因融合而改变。“具有 BCOR 改变的中枢神经系统高级神经上皮肿瘤”是一种最近描述的实体,其特征是 BCOR 基因外显子 15 内的串联重复(以下简称:CNS HGNET-BCOR ex15 ITD)。在这 3 例患者的病例系列中,我们报告了具有新型 EP300-BCOR 框内基因融合的神经胶质瘤的临床病理、分子和甲基组学特征,从而扩大了中枢神经系统肿瘤中 BCOR 改变的范围。该系列中的神经胶质瘤发生在儿童(10-18 岁),累及幕上腔,具有浸润性生长模式和黏液样/微囊状背景,常有沙粒状钙化和明显的铁丝网样血管。所有 3 例均有低级别形态区域,其中 2 例表现为组织学高级别转化。与 CNS HGNET-BCOR ex15 ITD 不同,它们缺乏血管周围假玫瑰结。在 t 分布随机邻体嵌入图上,它们完美地聚集在一起,远离 CNS HGNET-BCOR ex15 ITD,这与不同的实体一致。具有 EP300-BCOR 融合和高级别组织学的神经胶质瘤在去瘤或次全切除后可能会迅速复发。

相似文献

1
Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.具有独特临床病理特征的小儿脑肿瘤中 EP300-BCOR 融合的反复出现。
J Neuropathol Exp Neurol. 2019 Apr 1;78(4):305-314. doi: 10.1093/jnen/nlz011.
2
High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.伴有 BCOR 外显子 15 内串联重复的高级别神经上皮肿瘤:全面的临床、影像学、病理学和基因组分析。
Brain Pathol. 2020 Jan;30(1):46-62. doi: 10.1111/bpa.12747. Epub 2019 Jun 10.
3
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.高级别神经上皮肿瘤伴 EP300::BCOR 融合和 BCOR 免疫组化阴性:病例报告。
Brain Tumor Pathol. 2023 Apr;40(2):133-141. doi: 10.1007/s10014-023-00451-y. Epub 2023 Feb 22.
4
CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.中枢神经系统高级别神经上皮肿瘤伴 BCOR 内部串联重复:与肾脏和软组织中的对应物的比较。
Brain Pathol. 2018 Sep;28(5):710-720. doi: 10.1111/bpa.12585. Epub 2017 Dec 28.
5
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.BCOR 和 CREBBP 融合在浸润性神经胶质瘤中是罕见事件。
Acta Neuropathol Commun. 2020 Jun 3;8(1):80. doi: 10.1186/s40478-020-00951-4.
6
Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?中枢神经系统高级别神经上皮肿瘤伴 BCOR 免疫阳性:是否存在分子异质性?
Brain Tumor Pathol. 2021 Jan;38(1):41-49. doi: 10.1007/s10014-020-00381-z. Epub 2020 Sep 27.
7
HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.小脑 HGNET-BCOR 肿瘤:3 例的临床病理和分子特征。
Am J Surg Pathol. 2017 Sep;41(9):1254-1260. doi: 10.1097/PAS.0000000000000866.
8
CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.具有 CREBBP::BCORL1 融合和 BCOR 和 CREBBP 致病性突变的中枢神经系统肿瘤:扩大 BCOR 改变的肿瘤谱。
Acta Neuropathol Commun. 2024 Jan 12;12(1):8. doi: 10.1186/s40478-024-01726-x.
9
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.中枢神经系统肿瘤伴 EP300::BCOR 融合:探讨其在成年人群中的流行情况。
Acta Neuropathol Commun. 2023 Feb 13;11(1):26. doi: 10.1186/s40478-023-01523-y.
10
BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.BCOR::CREBBP 融合型中枢神经系统恶性神经上皮肿瘤扩大了具有 BCOR/BCOR(L1)-融合的甲基化类中枢神经系统肿瘤谱。
Acta Neuropathol Commun. 2024 Apr 18;12(1):60. doi: 10.1186/s40478-024-01780-5.

引用本文的文献

1
CNS Tumor with BCOR/BCORL1 Fusion: A Rare Tumor Entity.伴有BCOR/BCORL1融合的中枢神经系统肿瘤:一种罕见的肿瘤实体。
Int J Mol Sci. 2025 Jul 14;26(14):6729. doi: 10.3390/ijms26146729.
2
Epigenetic modifications and their roles in pediatric brain tumor formation: emerging insights from chromatin dysregulation.表观遗传修饰及其在儿童脑肿瘤形成中的作用:染色质失调的新见解
Front Oncol. 2025 Jun 17;15:1569548. doi: 10.3389/fonc.2025.1569548. eCollection 2025.
3
cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics.
cIMPACT-NOW更新9:关于全基因组DNA甲基化谱在中枢神经系统肿瘤诊断中的应用建议。
Neurooncol Adv. 2025 Jan 3;7(1):vdae228. doi: 10.1093/noajnl/vdae228. eCollection 2025 Jan-Dec.
4
BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.BCOR::CREBBP 融合型中枢神经系统恶性神经上皮肿瘤扩大了具有 BCOR/BCOR(L1)-融合的甲基化类中枢神经系统肿瘤谱。
Acta Neuropathol Commun. 2024 Apr 18;12(1):60. doi: 10.1186/s40478-024-01780-5.
5
CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.具有 CREBBP::BCORL1 融合和 BCOR 和 CREBBP 致病性突变的中枢神经系统肿瘤:扩大 BCOR 改变的肿瘤谱。
Acta Neuropathol Commun. 2024 Jan 12;12(1):8. doi: 10.1186/s40478-024-01726-x.
6
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.表现为低级别癫痫相关性神经上皮肿瘤的伴有EP300::BCOR融合的小儿弥漫性胶质瘤:病例报告
Brain Tumor Pathol. 2024 Jan;41(1):35-39. doi: 10.1007/s10014-023-00475-4. Epub 2023 Dec 22.
7
Management and Molecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series.脑室内脑胶质瘤的管理和分子特征:单机构病例系列。
Int J Mol Sci. 2023 Aug 27;24(17):13285. doi: 10.3390/ijms241713285.
8
Report two adult cases of high-grade neuroepithelial neoplasm harbouring EP300::BCOR fusions with comprehensive molecular detection.报告两例通过全面分子检测发现携带EP300::BCOR融合的高级别神经上皮肿瘤成人病例。
Brain Pathol. 2023 Nov;33(6):e13177. doi: 10.1111/bpa.13177. Epub 2023 Jun 2.
9
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.高级别神经上皮肿瘤伴 EP300::BCOR 融合和 BCOR 免疫组化阴性:病例报告。
Brain Tumor Pathol. 2023 Apr;40(2):133-141. doi: 10.1007/s10014-023-00451-y. Epub 2023 Feb 22.
10
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.具有EP300::BCOR融合的胶质瘤的分子和临床病理特征
Acta Neuropathol. 2022 Dec;144(6):1175-1178. doi: 10.1007/s00401-022-02508-2. Epub 2022 Oct 6.